The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Levinson, D. F.
* Articles by Musthaq, M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Levinson, D. F.
* Articles by Musthaq, M.
Related Collections
* Miscellaneous Mood Disorders
* Schizophrenia Spectrum Disorders
* Antidepressants
* Other Neuroleptics
Am J Psychiatry 156:1138-1148, August 1999
© 1999 American Psychiatric Association


Special

Treatment of Schizoaffective Disorder and Schizophrenia With Mood Symptoms

Douglas F. Levinson, M.D., C. Umapathy, M.D., and Mohamado Musthaq, M.D.

ABSTRACT

OBJECTIVE: Patients with concurrent schizophrenic and mood symptoms are often treated with antipsychotics plus antidepressant or thymoleptic drugs. The authors review the literature on treatment of two overlapping groups of patients: those with schizoaffective disorder and those with schizophrenia and concurrent mood symptoms. METHOD: MEDLINE searches (from 1976 onward) were undertaken to identify treatment studies of both groups, and references in these reports were checked. Selection of studies for review was based on the use of specified diagnostic criteria and of parallel-group, double-blind design (or, where few such studies addressed a particular issue, large open studies). A total of 18 treatment studies of schizoaffective disorder and 15 of schizophrenia with mood symptoms were selected for review. RESULTS: For acute exacerbations of schizoaffective disorder or of schizophrenia with mood symptoms, antipsychotics appeared to be as effective as combination treatments, and there was some evidence for superior efficacy of atypical antipsychotics. There was evidence supporting adjunctive antidepressant treatment for schizophrenic and schizoaffective patients who develop a major depressive syndrome after remission of acute psychosis, but there were mixed results for treatment of subsyndromal depression. There was little evidence to support adjunctive lithium for depressive symptoms and no evidence concerning its use for manic symptoms in patients with schizophrenia. CONCLUSIONS: Empirical data suggest that both groups of patients are best treated by optimizing antipsychotic treatment and that atypical antipsychotics may prove to be most effective. Adjunctive antidepressants may be useful for patients with major depression who are not acutely ill. Careful longitudinal assessment is required to ensure identification of primary mood disorders.




This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
M. Olfson, S. C. Marcus, and G. J. Wan
Treatment Patterns for Schizoaffective Disorder and Schizophrenia Among Medicaid Patients
Psychiatr Serv, February 1, 2009; 60(2): 210 - 216.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
A. Tiwari, M. Rajan, D. Miller, L. Pogach, M. Olfson, and U. Sambamoorthi
Guideline-Consistent Antidepressant Treatment Patterns Among Veterans With Diabetes and Major Depressive Disorder
Psychiatr Serv, October 1, 2008; 59(10): 1139 - 1147.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
S. Burton
Symptom domains of schizophrenia: the role of atypical antipsychotic agents
J Psychopharmacol, November 1, 2006; 20(6_suppl): 6 - 19.
[Abstract] [PDF]


Home page
Psychiatr. Serv.Home page
M. H. Chakos, I. D. Glick, A. L. Miller, M. B. Hamner, D. D. Miller, J. K. Patel, A. Tapp, R. S. E. Keefe, and R. A. Rosenheck
Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial
Psychiatr Serv, August 1, 2006; 57(8): 1094 - 1101.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. Mohl, K. Westlye, S. Opjordsmoen, A. Lex, A. Schreiner, M. Benoit, P. Braunig, and R. Medori
Long-acting risperidone in stable patients with schizoaffective disorder
J Psychopharmacol, September 1, 2005; 19(5_suppl): 22 - 31.
[Abstract] [PDF]


Home page
FocusHome page
M. D. Jibson, I. D. Glick, and R. Tandon
Schizophrenia and Other Psychotic Disorders
Focus, January 1, 2004; 2(1): 17 - 30.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Ment. HealthHome page
C. G Kohler
Review: the case for antidepressants for treating depression in people with schizophrenia remains unproven
Evid. Based Ment. Health, November 1, 2003; 6(4): 113 - 113.
[Full Text] [PDF]


Home page
NEJMHome page
R. Freedman
Schizophrenia
N. Engl. J. Med., October 30, 2003; 349(18): 1738 - 1749.
[Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
M. A. Escamilla
Diagnosis and Treatment of Mood Disorders That Co-occur With Schizophrenia
Psychiatr Serv, July 1, 2001; 52(7): 911 - 919.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org